Mark A. Goldsmith - Aug 9, 2022 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Stock symbol
RVMD
Transactions as of
Aug 9, 2022
Transactions value $
$5,065
Form type
4
Date filed
8/10/2022, 05:01 PM
Previous filing
Mar 21, 2022
Next filing
Aug 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $5.06K +10.3K +5.54% $0.49* 197K Aug 9, 2022 Direct F4, F5
holding RVMD Common Stock 37K Aug 9, 2022 Trust F1
holding RVMD Common Stock 37K Aug 9, 2022 Trust F2
holding RVMD Common Stock 267K Aug 9, 2022 Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -10.3K -6.16% $0.00 157K Aug 9, 2022 Common Stock 10.3K $0.49 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F2 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F3 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
F4 Includes 130,500 RSUs.
F5 Includes 937 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022.

Remarks:

President and Chief Executive Officer